Degradation of uric acid and 3-ribosyluric acid during treatment with charcoal
โ Scribed by Robert C. Smith
- Publisher
- Elsevier Science
- Year
- 1981
- Tongue
- English
- Weight
- 892 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0026-265X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Several factors, including metabolic profile, are predictive of response to standard antiviral therapy in patients with chronic hepatitis C. In a retrospective study, it was investigated whether uric acid, involved in metabolic syndrome, could be included. A total of 153 patients (56.2%
The peroxisome proliferators perfluorooctanoic acid (PFOA; 0.02% w/w), perfluorodecanoic acid (PFDA; 0.02%, w/w), nafenopin (0.125%, w/w), clofibrate (0.5%, w/w), and acetylsalicylic acid (ASA; 1%, w/w) were administered to male C57 BL/6 mice in their diet for two weeks. Parameters for Fe3+ADP, NADP
## Response to "Treatment of Childhood Chronic ITP" Prompted by recent correspondence in the Journal (July 1994), may I contribute the experience from this center in the use of megadose prednisone for chronic immune thrombocytopenic purpura (ITP) in children? A cohort of 4 children received this
## Abstract Until now the composition of the complex porphyrin mixtures of hematoporphyrin derivative (HPD) and Photofrin II could not be clarified in detail. We investigated the applicability of oxidative degradation to the structural assignment of HPD constituents. Therefore, some fundamental wor